These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia. Hansen RJ; Balthasar JP J Pharm Sci; 2003 Jun; 92(6):1206-15. PubMed ID: 12761810 [TBL] [Abstract][Full Text] [Related]
69. A novel mouse strain optimized for chronic human antibody administration. Gupta A; Smith P; Bournazos S; Ravetch JV Proc Natl Acad Sci U S A; 2022 Mar; 119(10):e2123002119. PubMed ID: 35235456 [TBL] [Abstract][Full Text] [Related]
70. Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation. Gardinassi LG; Dotz V; Hipgrave Ederveen A; de Almeida RP; Nery Costa CH; Costa DL; de Jesus AR; Mayboroda OA; Garcia GR; Wuhrer M; de Miranda Santos IK mBio; 2014 Dec; 5(6):e01844. PubMed ID: 25467439 [TBL] [Abstract][Full Text] [Related]
71. Modulating IgG effector function by Fc glycan engineering. Li T; DiLillo DJ; Bournazos S; Giddens JP; Ravetch JV; Wang LX Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3485-3490. PubMed ID: 28289219 [TBL] [Abstract][Full Text] [Related]
72. One-step immobilization and purification of genetic engineering CBD fusion EndoS on cellulose for antibodies Fc-glycan remodeling. Zhao K; Tang F; Shi W; Hong H; Zhou Z; Huang W; Wu Z Bioorg Chem; 2019 Oct; 91():103114. PubMed ID: 31336307 [TBL] [Abstract][Full Text] [Related]
73. The isotype of autoantibodies influences the phagocytosis of antibody-coated platelets in autoimmune thrombocytopenic purpura. Hoemberg M; Stahl D; Schlenke P; Sibrowski W; Pachmann U; Cassens U Scand J Immunol; 2011 Nov; 74(5):489-95. PubMed ID: 21790706 [TBL] [Abstract][Full Text] [Related]
74. Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation. Castilho A; Gruber C; Thader A; Oostenbrink C; Pechlaner M; Steinkellner H; Altmann F MAbs; 2015; 7(5):863-70. PubMed ID: 26067753 [TBL] [Abstract][Full Text] [Related]
75. Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors. Ortiz DF; Lansing JC; Rutitzky L; Kurtagic E; Prod'homme T; Choudhury A; Washburn N; Bhatnagar N; Beneduce C; Holte K; Prenovitz R; Child M; Killough J; Tyler S; Brown J; Nguyen S; Schwab I; Hains M; Meccariello R; Markowitz L; Wang J; Zouaoui R; Simpson A; Schultes B; Capila I; Ling L; Nimmerjahn F; Manning AM; Bosques CJ Sci Transl Med; 2016 Nov; 8(365):365ra158. PubMed ID: 27856797 [TBL] [Abstract][Full Text] [Related]
76. A novel secreted endoglycosidase from Enterococcus faecalis with activity on human immunoglobulin G and ribonuclease B. Collin M; Fischetti VA J Biol Chem; 2004 May; 279(21):22558-70. PubMed ID: 15028731 [TBL] [Abstract][Full Text] [Related]
77. Fab-mediated binding of glycoprotein Ib/IX and IIb/IIIa specific antibodies in chronic idiopathic thrombocytopenic purpura. Hou M; Stockelberg D; Kutti J; Wadenvik H Br J Haematol; 1995 Dec; 91(4):944-50. PubMed ID: 8547147 [TBL] [Abstract][Full Text] [Related]
78. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans. Goetze AM; Liu YD; Zhang Z; Shah B; Lee E; Bondarenko PV; Flynn GC Glycobiology; 2011 Jul; 21(7):949-59. PubMed ID: 21421994 [TBL] [Abstract][Full Text] [Related]
79. Possible presence of enhancing antibodies in idiopathic thrombocytopenic purpura. Yang YY; Fischer P; Leu SJ; Zhu M; Woods VL; Chen PP Br J Haematol; 1999 Jan; 104(1):69-80. PubMed ID: 10027714 [TBL] [Abstract][Full Text] [Related]
80. N-linked glycan structures of the human Fcγ receptors produced in NS0 cells. Cosgrave EF; Struwe WB; Hayes JM; Harvey DJ; Wormald MR; Rudd PM J Proteome Res; 2013 Aug; 12(8):3721-37. PubMed ID: 23777450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]